Patients who were taking lipid-lowering medications experienced more severe anaphylaxis after insect stings, according to an ...
The U.S. Senate confirmed Robert F. Kennedy Jr. as the nation’s next health and human services secretary on Thursday, ...
ALBANY — An investigation into a series of episodes in which state prison workers have been rushed to hospitals after ...
New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study ...
16d
Everyday Health on MSNCommon MS Drug Causes Rare but Potentially Deadly Allergic Reactions, FDA WarnsThe FDA noted that 82 people taking these glatiramer acetate medications required ER visits or hospitalizations, and 6 others ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Alpha-gal syndrome was discovered because of unexpected severe drug reactions, including anaphylaxis, in some patients who took cetuximab, a cancer drug. A 2008 study found antibodies to alpha-gal ...
FDA adds boxed warning to a multiple sclerosis drug, citing rare but severe risk. Today, the FDA issued a warning about the risk of anaphylaxis, a rare but life-threatening allergic reaction ...
Jan 22 (Reuters) - The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use of some multiple sclerosis drugs including Teva's ...
Triple click chemistry has revolutionized chemical synthesis with its simplicity and efficiency, allowing for the quick and selective assembly of complex molecules. Now, in a recent study, researchers ...
GLP1 receptor agonists are widely prescribed to help control blood sugar levels and support weight loss. While these ...
New Boxed Warning added to highlight the risk of severe allergic reactions at any stage of treatment. Brand New Membership Level: Benzinga Trade Alerts The U.S. Food and Drug Administration (FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results